Key result
Peri-infarct dysglycemia links to ~5-point larger infarct size and worse event-free survival.
Why the study?
The reasons why mortality improvements in normoglycaemic AMI patients have not been matched in diabetic patients are not completely understood, motivating evaluation of whether peri-infarct glycaemic control impacts infarct size, LVEF, and prognosis.
Does peri-infarct dysglycaemia or diabetes mellitus increase myocardial infarct size and worsen event-free survival compared to normoglycaemia in patients with a first acute myocardial infarction?
Cohort (n=93)
Does peri-infarct dysglycaemia or diabetes mellitus increase myocardial infarct size and worsen event-free survival compared to normoglycaemia in patients with a first acute myocardial infarction?
Peri-infarct dysglycaemia and diabetes mellitus are associated with significantly larger myocardial infarct sizes on CMR at baseline and 11 months, which may explain their worse 18-month event-free survival after a first AMI.
Answers are grounded in this paper and cite their sources.
May identify dysglycaemic patients for closer post-MI surveillance; leaves open causal mechanisms of larger infarct size.
Methods Ninety-three patients with first acute myocardial infarction (AMI) were studied. 22 patients had diabetes mellitus (DM) based on prior history or admission blood glucose ≥ 11.1 mmol/l. 13 patients had dysglycaemia (admission blood glucose ≥ 7.8 mmol/l but <11.1 mmol/l) and 58 patients had normoglycaemia (admission blood glucose <7.8 mmol/l). Patients underwent CMR imaging at index presentation and at median follow-up of 11 months. The CMR protocol was identical for all patients and included cine imaging and late gadolinium enhancement. Results Patients with dysglycaemia and DM had larger infarct sizes by CMR than normoglycaemic patients, at baseline (mean (standard deviation, SD) % LV scar 23.0 (10.9), 25.6 (12.9) and 15.8 (10.3) respectively, overall p = 0.001) and at 11 months (mean (SD) % LV scar 17.6 (8.9), 19.1 (9.6) and 12.4 (7.8) respectively, overall p = from 13th Annual SCMR Scientific Sessions Phoenix, AZ, USA. 21-24 January 2010
No takes yet. Share an insight, caveat, or question.
Mather et al. (2010) conducted a cohort in First acute myocardial infarction (AMI) (n=93). Peri-infarct dysglycaemia or diabetes mellitus vs. Normoglycaemia (admission blood glucose <7.8 mmol/l) was evaluated on Myocardial infarct size (% LV scar) by CMR at 11 months (p=0.017). Peri-infarct dysglycaemia and diabetes mellitus were associated with larger infarct sizes at 11 months and lower 18-month event-free survival.
Synapse has enriched 10 related papers. Consider them for comparative context: